Company Filing History:
Years Active: 2009-2018
Title: The Innovative Contributions of Jill Gregory
Introduction
Jill Gregory is a prominent inventor based in Acton, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of 2 patents, her work has the potential to impact the treatment of various diseases.
Latest Patents
Jill Gregory's latest patents include innovative solutions such as NAMPT inhibitors and methods. This invention features compounds of Formula (I), Formula (I)-A, and Formula (I)-B, along with methods of synthesis, therapy, diagnostics, and assays. Another notable patent is for Tetrahydroisoquinoline derivatives for treating protein trafficking diseases. This patent discloses pharmaceutical compositions that are useful in treating diseases mediated by chloride channel activity and/or protein trafficking. These compounds are particularly relevant for conditions associated with impaired mucociliary clearance, including cystic fibrosis, bronchitis, and emphysema.
Career Highlights
Jill Gregory is currently associated with Genzyme Corporation, where she continues to advance her research and development efforts. Her work at Genzyme has positioned her as a key player in the pharmaceutical industry, focusing on innovative treatments that address complex health challenges.
Collaborations
Jill collaborates with talented professionals in her field, including coworkers Paul Mason and Kara Carter. These collaborations enhance her research capabilities and contribute to the success of her projects.
Conclusion
Jill Gregory's innovative contributions to the pharmaceutical industry through her patents and collaborations highlight her commitment to improving health outcomes. Her work continues to pave the way for advancements in the treatment of critical diseases.